Methods of treating kidney disease and protecting podocytes from injury are provided. Methods of screening agents for the treatment of kidney disease are also provided. In addition, methods of identifying structural or functional defects in a patients podocytes and methods of identifying kidney disease causing agents in a patients biological sample are also provided.
